Will Zika see 'big private sector action'?
The private sector has played a limited role in the Zika response so far. But U.S. officials are hinting that could change soon.
By Jeff Tyson // 20 May 2016As the international community struggles to mobilize funds and resources to take on the Zika virus outbreak, pandemic experts have asked why the private sector has not played a bigger role in critical elements of response such as diagnostic testing. But that could change soon. “We really don’t have a good test and we don’t so far have a lot of private sector partners who are ready to scale up the technology to make diagnostic tests,” Patrick Kachur, medical officer at the U.S. Centers for Disease Control and Prevention said at the Center for Strategic and International Studies in Washington, D.C., on Thursday. As a result, CDC laboratories have had to work “around the clock” on diagnostic testing, Kichur said. He also told Devex that the public health agency “has had to do more heavy lifting than we’re really good at.” But the private sector’s role in the Zika response could soon ramp up, hinted Amy Pope, deputy homeland security adviser and deputy national security adviser at the White House National Security Council. “We’re actually hopeful that we’ll have some big private sector action in the coming weeks that we’ll be able to announce,” Pope said. In February, the White House requested $1.9 billion to support domestic and international efforts to combat the mosquito-borne disease, but so far the U.S. Congress has not appropriated that sum. The Senate voted Tuesday to make available $1.1 billion, and on Wednesday the House of Representatives approved $622 million in Zika funding. The Obama administration called the House proposal “woefully inadequate.” Stay tuned to Devex for more news and analysis of U.S. aid, and subscribe to The Development Newswire to receive the latest from the world’s leading donors and decision-makers — emailed to you FREE every business day.
As the international community struggles to mobilize funds and resources to take on the Zika virus outbreak, pandemic experts have asked why the private sector has not played a bigger role in critical elements of response such as diagnostic testing.
But that could change soon.
“We really don’t have a good test and we don’t so far have a lot of private sector partners who are ready to scale up the technology to make diagnostic tests,” Patrick Kachur, medical officer at the U.S. Centers for Disease Control and Prevention said at the Center for Strategic and International Studies in Washington, D.C., on Thursday.
This article is free to read - just register or sign in
Access news, newsletters, events and more.
Join usSign inPrinting articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
Jeff is a former global development reporter for Devex. Based in Washington, D.C., he covers multilateral affairs, U.S. aid, and international development trends. He has worked with human rights organizations in both Senegal and the U.S., and prior to joining Devex worked as a production assistant at National Public Radio. He holds a master's degree in journalism from Columbia University and a bachelor’s degree in international relations and French from the University of Rochester.